Human Reproduction · 2007 · 262 citations · 60 references
MedicineGynecologySurgeryReproductive EndocrinologyReproductive MedicineWomen's HealthDiminished Ovarian ReserveMenopause CareMenopause ManagementOvarian ReserveUterine FibroidsAnti-müllerian Hormone AssessmentAnti-müllerian Hormone TestingMenopausal StatusOvarian Reserve DepletionOvarian Reserve DiminutionRandomized Controlled Trial Baseline
BACKGROUND: Ovarian failure as a complication of uterine artery embolization (UAE) for symptomatic uterine fibroids has raised concerns about this new treatment modality. METHODS: We investigated the occurrence of ovarian reserve reduction in a randomized trial comparing UAE and hysterectomy by measuring follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH). A total of 177 pre-menopausal women with menorrhagia due to uterine fibroids were included (UAE:n=88; hysterectomy:n=89). FSH and AMH were measured at baseline and at several time-points during the 24 months follow-up period. Follow-up AMH levels were also compared to the expected decrease due to ovarian ageing during the observational period. RESULTS: FSH increased significantly compared to baseline in both groups after 24 months follow-up (within group analysis: UAE:+12.1; P=0.001; hysterectomy:+16.3; P<0.0001). No differences in FSH values between the groups were found (P=0.32). At 24 months after treatment the number of patients with FSH levels>40 IU/l was 14/80 in the UAE group and 17/73 in the hysterectomy group (relative risk=0.75; P=0.37). AMH was measured in 63 patients (UAE: n=30; hysterectomy: n=33). After treatment AMH levels remained significantly decreased during the entire follow-up period only in the UAE group compared to the expected AMH decrease due to ageing. No differences were observed between the groups. CONCLUSIONS: This study shows that both UAE and hysterectomy affect ovarian reserve. This results in older women becoming menopausal after the intervention. Therefore, the application of UAE in women who still wish to conceive should only be considered after appropriate counselling.
60
Arterial embolisation to treat uterine myomata
J Ravina, N Ciraru‐Vigneron, J.M. Bouret et al. · The Lancet · 1995 · 1.1K citations
Medicine, Gynecology, Surgery +10
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
Ilse A.J. van Rooij · Human Reproduction · 2002 · 950 citations · Full text
Medicine, Endocrinology, Gynecology +17
Antimüllerian hormone serum levels: a putative marker for ovarian aging
Annemarie de Vet, Joop S.E. Laven, Frank H. de Jong et al. · Fertility and Sterility · 2002 · 886 citations · Full text
Medicine, Endocrinology, Gynecology +14
Clinical Gynecologic Endocrinology and Infertility
Ilinca Gussi · Acta Endocrinologica (Bucharest) · 2005 · 766 citations
Medicine, Endocrinology, Gynecology +12
Executive summary: stages of reproductive aging workshop (STRAW)
Michael R. Soules, Sherry Sherman, Estella C. Parrott et al. · Fertility and Sterility · 2001 · 756 citations